The research group on Cell Signaling and Bone Biology at IDIBELL and the UB has revealed the importance of the function of NRF2, a protein that regulates the expression of some genes in response to ox...
Read moreDrug-resistant fungal infections are a growing problem. The work has been published in the journal Current Biology
Read moreThe new drug incorporates the necessary pharmaceutical technology to allow the adjustment of the dosage according to the weight of the dog
Read moreThe start-ups Oxolife, Peptomyc and aptaTargets, with which GENESIS Biomed collaborates, are advancing in their maturity with the initiation and development of clinical phases and are approaching an e...
Read moreLike cutaneous melanomas, it is caused by the uncontrolled proliferation of melanocytes, the cells that colored the skin. But unlike these, uveal melanoma, which represents between 3 and 5% of melanom...
Read moreThe safety, availability, and robust biological effect of metoprolol could together be enough to consider its use in young patients admitted to the ICU with severe COVID-19
Read moreIt has long been known that obesity is an inflammatory disease, i.e. a chronic defensive reaction of the body to stress caused by excess nutrients.
Read moreAre you developing a drug and need help with regulatory affairs?
Read moreA recent study has confirmed the benefits of the drug leriglitazone in treating Friedrich's Ataxia, a rare disease that affects 2-4 people in 100,000 and for which there is currently no effective cure...
Read moreThings are going well for your latest drug molecule - it seems efficacious, you have assessed potential toxicity, and even determined a safe starting dose, and now you are ready to move to the clinic...
Read moreDr. Kulisevsky, director of the Movement Disorders Unit of the Sant Pau Hospital Neurology Service and head of the Parkinson’s Disease and Movement Disorders Research Group at the Sant Pau Research ...
Read moreUdL research questions use of 3-methyladenine in studies because of its toxicity
Read more